Subcutaneous golimumab induced and maintained clinical response in a child with a biological-experienced steroid-refractory flare of ulcerative colitis: A case report
Conclusion:
Golimumab has shown potential efficacy and safety in the treatment of ulcerative colitis in children which may indicate a significant future role for subcutaneous golimumab in pediatrics ulcerative colitis.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Clinical Case Report Source Type: research
More News: Anemia | Arthritis | Asacol | Bleeding | Children | Clostridium Difficile | Colectomy | Colonoscopy | Corticosteroid Therapy | Cytomegalovirus | Gastroenteritis | Gastrointestinal Polyps | Humira | Inflammatory Bowel Disease | Internal Medicine | Lialda | Middle East Health | Pain | Parasitic Diseases | Parasitology | Pediatrics | Polyps | Prograf | Remicade | Restasis | Rheumatology | Sigmoidoscopy | Study | Syria Health | Tacrolimus | Ulcerative Colitis